Abstract: The automation of laboratory and data workflows within AstraZeneca’s Analytical Sciences (AS) function of Biopharmaceutical Development (BPD), is becoming ever more critical to support an increasingly demanding pipeline. Investment in this area to automate manual processes has the potential to provide better utilisation of a talented and diverse workforce, bringing significant productivity gains necessary to deliver the portfolio. AS have developed a suite of physical and data automation workflows to increase throughput, whilst continuing to deliver the same high quality analytical data to our colleagues across BPD. Here we discuss the implementation of a variety of automation solutions and approximate their value/impact to the business. We also discuss lessons learned and touch on future endeavours to expand our automation toolbox and realise our Automation vision.
